Peptide VP treatment showed a trend for increasing Treg cells, decreasing Th17 cells, increasing the ratio of Treg/Th17 in the spleens and PLN, but there was no significant difference.
← all excerpts
Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation.
1
—
—